Coronavirus

Pfizer, BioNTech begin coronavirus vaccine trials in kids, publish early-stage data

While this week brought along pauses in coronavirus trials for Johnson and Johnson’s vaccine candidate and Eli Lilly’s antibody treatment over safety concerns, Pfizer and BioNTech published early-stage data of a vaccine candidate now in Phase 3, and marked the first company in the U.S. to begin COVID-19 vaccination trials in teens.